Accord Logo

Intended for UK patients and members of the public

SmPC - Carboplatin 10 mg/ml concentrate for solution for infusion: Change history

  • To update sections 4.3, 4.4, 4.6, 4.8, 5.1 of the SmPC and

    sections 2, 4 of the PIL in line with the reference product Carboplatin Hospira 10 mg/ml Onco-Tain, concentrate for solution for infusion 10 mg/ml; MAH: Pfizer eg; National authorisation number: RVG 23321.

     

    Additionally, the typographical error in ATC code in sections 5.1 of the SmPC has been corrected. SmPC section 4.8 ‘Reporting of SARs’ subsection has also been updated in line with QRD. Editorial updates have been made to the PIL.

    • Changes: (Updated: 14 Aug 2024)

      To update sections 4.3, 4.4, 4.6, 4.8, 5.1 of the SmPC and

      sections 2, 4 of the PIL in line with the reference product Carboplatin Hospira 10 mg/ml Onco-Tain, concentrate for solution for infusion 10 mg/ml; MAH: Pfizer eg; National authorisation number: RVG 23321.

       

      Additionally, the typographical error in ATC code in sections 5.1 of the SmPC has been corrected. SmPC section 4.8 ‘Reporting of SARs’ subsection has also been updated in line with QRD. Editorial updates have been made to the PIL.

    • Changes: (Updated: 15 Jun 2023)

      Description of update: Variation type IB no: C.I.3.z To update the SmPC and PIL in line with wording of PSUSA/00000559/202201.

      SmPC sections updated: 4.4, 4.8, 10.

    • Changes: (Updated: 09 Nov 2022)

      Updated

    • Changes: (Updated: 20 Sep 2022)

      Initial upload

    View product information as a: